NF2 and meningioma: Because of the high prevalence of NF2 alterations in the atypical cohort, a tumour harbouring NF2 loss has a 3.78 times greater risk to be atypical compared with a non-NF2 meningioma (P=2.2 × 10−10, Fisher’s exact test).